Search

everythinglearnresearchcommunity

for

Search:↓

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Different forms of FGF5 either promote or inhibit hair growth.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride and finasteride affect different cell types differently.

A new compound shows promise as a topical treatment for hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

ESR2 gene linked to female-pattern hair loss.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The Hairless gene is crucial for healthy skin and hair growth.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.